Cornerstone Robotic, a leading global innovator in surgical robotics, has successfully raised over $70 million in Series C financing led by EQT with participation from Qiming Venture Partners, Alpha JWC Ventures, the Innovation and Technology Venture Fund, eGarden Ventures, CTS Funds, K2VC, Long-Z Capital, etc.
This funding will accelerate the startup's efforts in advancing the commercialisation process, developing new surgical robotics products, conducting clinical trials, obtaining regulatory approvals, and promoting global adoption of advanced robotic surgical solutions.
In addition to receiving funding from a group of prominent investors, the company headquartered in Hong Kong and the Greater Bay Area, also received investment from the Innovation and Technology Venture Fund under the Innovation and Technology Commission of the Hong Kong Special Administrative Region Government. The endorsement underscores confidence for Cornerstone Robotics' product innovation and global commercialization capabilities. This backing will further enable the company to expand into key geographies, including countries in Europe, Southeast Asia and across global markets.
Since its establishment in September 2019, Cornerstone Robotics has aimed to revolutionise healthcare by making advanced surgical systems accessible globally. Through in-house R&D and vertical supply chain integration, Cornerstone Robotics delivers high-quality performance at competitive prices, enabling partnerships with leading medical centers in mainland China, Hong Kong, and Europe, including the Faculty of Medicine of the Chinese University of Hong Kong, and Chinese University of Hong Kong-Shenzhen Medicine. The company's successful clinical trials in multiple specialties – including urology, general surgery, gynecology and thoracic surgeries – have built a solid foundation for international expansion.
